News Conference News ACC 2021 Cooling OHCA Patients to 31°C Not Superior to 34°C: CAPITAL-CHILL Caitlin E. Cox May 26, 2021
News Conference News ACC 2021 Extended TAILOR-PCI Data Again Show No Gains for Genotype-Guided Meds Yael L. Maxwell May 26, 2021
News Conference News ACC 2021 FFR Doesn’t Beat Angio for Complete Revasc in STEMI: FLOWER-MI Caitlin E. Cox May 25, 2021
News Conference News ACC 2021 Sotagliflozin Beneficial Across a Range of Patients, Including HFpEF Michael O'Riordan May 25, 2021
News Conference News ACC 2021 Global STEMI Initiative Helps Low- and Middle-Income Countries Achieve Better Metrics L.A. McKeown May 24, 2021
News Conference News ACC 2021 Rivaroxaban Helps Prevent More Events Than Aspirin Alone After Leg Interventions L.A. McKeown May 21, 2021
News Conference News ACC 2021 Complete Revascularization Analysis of ISCHEMIA Opens ‘Pandora’s Box’ Michael O'Riordan May 18, 2021
News Conference News ACC 2021 Omecamtiv Mecarbil Has Biggest Benefit at Lowest EFs Todd Neale May 18, 2021
News Conference News ACC 2021 Hyperinvasive Approach May Boost Survival in OHCA Yael L. Maxwell May 18, 2021
Presentation ACC 2021 Randomized trial of high sensitivity Troponin T in the Emergency Department Presenter: Derek Chew May 18, 2021
News Conference News ACC 2021 RAFT-AF: No Benefit of AF Ablation for Heart Failure Patients Todd Neale May 17, 2021
News Conference News ACC 2021 Lancet Commission on CVD in Women Aims to Slash Global Burden Shelley Wood May 17, 2021
News Conference News ACC 2021 ACTION: Full-Dose Rivaroxaban Doesn’t Help in Hospitalized COVID-19 Todd Neale May 17, 2021
News Conference News ACC 2021 COVID-19 Doubled Burnout Rates in Cardiology Yael L. Maxwell May 17, 2021
News Conference News ACC 2021 Apixaban Curbs Subclinical Thrombosis After TAVI in Patients Without Prior OAC Michael O'Riordan May 17, 2021
News Conference News ACC 2021 TALOS-AMI Supports Clopidogrel De-escalation After Earlier Ticagrelor Post-PCI Yael L. Maxwell May 17, 2021
Presentation ACC 2021 Effect of a Hospital and Post-discharge Quality Improvement Intervention on Clinical Outcomes and Quality of Care for Patients With Heart Failure With Reduced Ejection Fraction Presenter: Adam DeVore May 17, 2021
Presentation ACC 2021 Benefits of SGLT1/2 Inhibition with Sotagliflozin in Heart Failure With Preserved Ejection Fraction Presenter: Deepak L. Bhatt May 17, 2021
News Conference News ACC 2021 Clopidogrel, Not Aspirin, for Post-DAPT Monotherapy After PCI: HOST-EXAM L.A. McKeown May 16, 2021